$25.15
-1.02 (-3.90%)
Open$26.18
Previous Close$26.17
Day High$26.18
Day Low$25.03
52W High$35.80
52W Low$6.13
Volume—
Avg Volume198.0K
Market Cap512.82M
P/E Ratio—
EPS$-4.71
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
-68.3% upside
Current
$25.15
$25.15
Target
$7.97
$7.97
$5.39
$7.97 avg
$9.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 515.9K | 555.7K | 44.14M |
| Net Income | -96,113,928 | -93,183,814 | -12,888,213 |
| Profit Margin | -158,800.0% | -150,860.0% | -29.2% |
| EBITDA | -98,350,748 | -100,649,801 | -17,594,581 |
| Free Cash Flow | — | — | -11,802,396 |
| Rev Growth | -7.2% | -7.2% | -3.2% |
| Debt/Equity | — | — | 0.27 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |